New technology in the form of a magnetically-assisted remote-controlled catheter (MARC) which could allow physicians to see and assess brain tissue more clearly while treating a stroke may hold promise, according to study authors who released their findings at the Society of NeuroInterventional Surgery (SNIS) 11th Annual Meeting in Colorado Springs, USA20140801
Silk Road Medical has announced the completion of enrolment in its pivotal ROADSTER study. The trial was the first of its kind to study the treatment of carotid artery stenosis by placing a stent via direct access to the common carotid artery in the neck in an entirely new minimally invasive procedure. The device under study is the company’s Enroute transcarotid neuroprotection system which incorporates proven surgical principles to protect the brain from a stroke during carotid angioplasty and stenting, and features a mechanism to divert dangerous debris away from the brain by temporarily reversing blood flow. Data from the trial will be used to support 510(k) clearance of the Enroute transcarotid neuroprotection system as well as pre-market approval of the Enroute transcarotid stent system
For the first time ever, a paralysed man has moved his fingers and hand with his own thoughts after an electronic neural bypass for spinal cord injuries that reconnects the brain directly to muscles, allowing voluntary and functional control of a paralysed limb. This innovation comes from a partnership between The Ohio State University Wexner Medical Center and Battelle.
The United States Preventive Services Task Force recommends against screening for asymptomatic carotid artery stenosis in the general adult population, according to a recommendation statement being published in Annals of Internal Medicine.
Larry Ambrose was diagnosed as having a stroke a few days after he woke up one night, wandered into his kitchen and couldn´t read the time on his microwave. Ambrose, like 25 percent of all stroke patients, experienced a cryptogenic ischemic stroke, meaning physicians were unable to determine a cause.
In a new study published online in the Journal of the American Heart Association, researchers at Columbia Engineering report that they have identified a new component of the biological mechanism that controls blood flow in the brain. Led by Elizabeth M. C. Hillman, associate professor of biomedical engineering, the team has demonstrated, for the first time, that the vascular endothelium plays a critical role in the regulation of blood flow in response to stimulation in the living brain.
A new or recurrent stroke occurs in around 795,000 Americans every year and causes approximately 137,000 deaths. But new research published in the journal Neurology suggests a diet higher in protein may reduce stroke risk.
Thirty patients were enrolled at four sites across Europe and will be followed up using traditional assessments post-procedure and at 30 days to include MACE (death, stroke, MI), and ipsilateral stroke (31 days to 1 year). In addition, DW-MRI (Diffusion Weighted Magnetic Resonance Imaging) is being done pre and post procedure and at 30 days, as well as ultrasound examination at 30 days and 1 year on every patient.
Cuando un cónyuge, un compañero sentimental o un padre tiene migrañas crónicas, toda la familia sufre, según un nuevo estudio.
os accidentes cerebrovasculares (ACV) normalmente afectan a las mujeres a una edad avanzada, pero los médicos comienzan ahora enfocarse en ayudarlas a reducir su riesgo a una edad más temprana.
Las dietas ricas en proteína parecen reducir el riesgo de accidente cerebrovascular (ACV) de una persona, sobre todo si es proteína animal magra, como el pescado, sugiere un análisis reciente.
The University of Texas Health Science Center at Houston (UTHealth) Medical School, in partnership with Memorial Hermann-Texas Medical Center (TMC), USA, has announced that the UTHealth Mobile Stroke Unit has successfully transported and helped save the life of its very first patient.
Keystone Heart has raised US$14 million in series B funding for cerebral protection devices. By protecting all brain territories, the TriGuard cerebral protection device is designed to minimise the risk of cerebral damage during transcatheter aortic valve implantation (TAVI) and other cardiovascular procedures.
Lately, flow diversion devices have been introduced to the clinical practice, offering endoluminal aneurysm occlusion by flow disruption. The most used flow diverter devices in the market, like Pipeline (Covidien) and Silk (Balt) as well as other new stents, are single-layer, low-porosity and self-expandable stents, forming high-coverage mesh that covers the aneurysm neck which simultaneously induces thrombosis of the aneurysm sac while preserving the patency of the adjacent small vessels. Alternatively, the Flow Re-direction Endoluminal Device (FRED; Microvention) is a novel flow diverter stent and has been in clinical use since 2012.
Fayyaz Ahmed, consultant neurologist, Hull and East Yorkshire Hospitals NHS Trust, UK, speaks to NeuroNews about transcranial magnetic stimulation, the systems being studied and the implications of National Institute for Health and Care Excellence (NICE) approval.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos